The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
about
Why a universal antiretroviral regimen?Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
P2860
The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
description
2017 nî lūn-bûn
@nan
2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@ast
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@en
type
label
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@ast
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@en
prefLabel
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@ast
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@en
P2093
P2860
P921
P1476
The ADVANCE study: a groundbre ...... iversal antiretroviral regimen
@en
P2093
Celicia Serenata
OPTIMIZE Consortium
Polly Clayden
Willem D F Venter
P2860
P304
P356
10.1097/COH.0000000000000389
P5008
P577
2017-05-19T00:00:00Z
2017-07-01T00:00:00Z